Investigation of the Protective Effects of Magnesium on Bupivacaine-Induced Toxicity at the Level of Colon Cell Culture
Authors:
- Ceren ÖnalCÖCeren Önal
- Kemal Tolga SaraçoğluKSKemal Tolga Saraçoğlu
- Ayten SaraçoğluAyten Saraçoğlu
- Beyza Nur ÖzkanBÖBeyza Nur Özkan
- Eray Metin GülerEGEray Metin Güler
- Gülten ArslanGAGülten Arslan
- Seçil Azime KarakuşSKSeçil Azime Karakuş
- Yekbun BulunYBYekbun Bulun
- Tomasz GaszynskiTomasz Gaszynski
- Pawel RatajczykPRPawel Ratajczyk
Open Access
- 24 July 2024
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 12 (8) , 1652
Abstract
The primary objective of this in vitro study was to prevent the risk of toxicity associated with bupivacaine, widely used in clinical practice, by using magnesium (Mg), a readily available and cost-effective element, as an adjuvant. We hypothesized that Mg might exhibit a protective effect against cytotoxicity in a colon cell culture model under conditions of bupivacaine-induced LAST. Our secondary aim was to investigate its effect on genotoxicity, apoptosis, and iROS. CCD-18Co cells were used in our study. Control group (group C), Bupivacaine group (group B), Magnesium group (group M), and Bupivacaine+Mg group (group BM) were created. The viability of CCD-18Co cells incubated for 24 h in group C was determined to be 100%. These cells were evenly divided, and bupivacaine was administered to group B at concentrations of 5 to 300 μM. In group M, doses of Mg at 0.625 to 320 mEq were added. It was determined that the maximum viability was observed at a Mg dose of 40 mEq (p < 0.05). In group BM, bupivacaine was administered at the same concentrations in combination with Mg (40 mEq), and cell viability was measured. DNA damage, apoptosis, and iROS were assessed at concentrations of bupivacaine by administering 40 mEq Mg. In group B, viability decreased dose-dependently in CCD-18Co (p < 0.05, p < 0.01, p < 0.001). In group BM, the viability decreased in cells at increasing concentrations compared to group C (p < 0.05, p < 0.01, p < 0.001), but the viability was affected positively compared to group B (p < 0.05). In group B, DNA damage increased (p < 0.05, p < 0.001). In group BM, DNA damage increased (p < 0.05, p < 0.001). However, in group BM, DNA damage levels were reduced compared to group B (p < 0.05, p < 0.01). In group B, apoptosis increased (p < 0.05, p < 0.001); in group BM, apoptosis increased (p < 0.001) compared to group C. However, in group BM, apoptosis decreased compared to group B (p< 0.05). iROS increased in group B (p < 0.05, p < 0.01, p < 0.01) and group BM (p < 0.05, p < 0.01, p < 0.001) compared to the group C. However, in group BM, iROS decreased in comparison to group B (p < 0.05). In conclusion, Mg exhibits a protective effect against bupivacaine-induced toxicity.Keywords
Funding Information
- Scientific Research Projects Coordination Unit (BAPKO) (2021/157)
This publication has 35 references indexed in Scilit:
- Bupivacaine Induces ROS-Dependent Autophagic Damage in DRG Neurons via TUG1/mTOR in a High-Glucose EnvironmentNeurotoxicity Research, 2022
- Magnesium sulphate prevents lipopolysaccharide-induced cell death in an in vitro model of the human placentaPregnancy Hypertension, 2016
- Use of Intravenous Fat Emulsion in the Emergency Department for the Critically Ill Poisoned PatientThe Journal of Emergency Medicine, 2016
- Intracellular magnesium level determines cell viability in the MPP+ model of Parkinson's diseaseBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2015
- Ropivacaine- and bupivacaine-induced death of rabbit annulus fibrosus cells in vitro: involvement of the mitochondrial apoptotic pathwayOsteoarthritis and Cartilage, 2015
- Human Chondrocyte Viability After Treatment With Local Anesthetic and/or Magnesium: Results From an In Vitro StudyArthroscopy, 2010
- Bupivacaine uncouples the mitochondrial oxidative phosphorylation, inhibits respiratory chain complexes I and III and enhances ROS production: Results of a study on cell culturesMitochondrion, 2010
- In Vitro Exposure to 0.5% Bupivacaine Is Cytotoxic to Bovine Articular ChondrocytesArthroscopy, 2006
- Lymphocyte DNA damage in patients with acute coronary syndrome and its relationship with severity of acute coronary syndromeMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2005
- DNA damage and rpair with age in individual human lymphocytesMutation Research/DNAging, 1990